Select Page
Download this Quickfact to Learn how to:
- Enhance your preclinical data by using next generation sequencing (NGS) and customized data analysis
- Gain in-depth biological insight through highly sensitive sequencing methodologies including PCR, RT-PCR and NGS
- Utilize our secure and convenient reporting options, which includes an expert consultation
Download this Quickfact to Learn about:
- Our online searchable database that allows you to search by gene expression, copy number, miRNA expression and more
- The world’s largest commercially available collection of PDX models ready for in vivo efficacy testing
- Which unique collections are part of HuBase e.g. underrepresented indications such as prostate cancer
Download this Quickfact to Learn:
- How you can register to to use this database to compare murine and humaized drug target models
- What model and profiling data is available within this database e.g. mouse strain and RNAseq data
- Which advanced genomic searches you can perform across our immuno-oncology platform
Download this Quickfact to Learn:
- How you can register for a one stop search engine for oncology models including PDX, cell line derived xenografts and syngeneic models
- The keyword search that is available across all platforms and models simultaneously, including cancer type and drug treatment
- How to access further relevant information such as phenotypic data and growth curves
Download this Quickfact to Learn:
- How you can explore a large selection of cell lines for in vitro and in vivo applications
- How in one click, XenoBase gives you instant access to a unique database of over 1,000 tumor cell lines and 200 cell line derived xenograft models
Download this Quickfact to Learn:
- How to find PDX- and patient-derived tumor organoids that best fit your in vitro oncology R&D programs
- What types of characterization data you can search for in OrganoidBase and cross-reference to PDX model details in HuBase, CrownBio’s extensive database of PXD models
Download this White Paper to Learn:
- The importance of cell line selection, using collated databases containing large cell line collections, or bespoke model creation
- How to select the correct downstream molecular biology assays to assess target expression, drug target inhibition, and tumor growth inhibition
- How an integrated in vitro, ex vivo, and in vivo oncology portfolio allows go/no go decisions to be made with confidence, using a single, uniquely positioned provider
Download this White Paper to Learn:
- The importance of cell line selection, using collated databases containing large cell line collections, or bespoke model creation
- How to select the correct downstream molecular biology assays to assess target expression, drug target inhibition, and tumor growth inhibition
- How an integrated in vitro, ex vivo, and in vivo oncology portfolio allows go/no go decisions to be made with confidence, using a single, uniquely positioned provider